The central target of $8.50 is the arithmetic mean of eight verified analyst price targets, with an approximate range of $4.50 to $12.00. At a recent price of about $1.45, reaching $8.50 would require a move of roughly 486%, an extraordinarily large advance.
Kodiak AI (KDK) fell from a previous close of $1.45 to about $1.29, a move of -11.03%, during regular market hours. No verified news or fundamental catalyst found; the drop is consistent with profit-taking after the prior two sessions surged +34.6% and +13.3% on the Q3 earnings beat and DTL 75-truck deal, typical of this low-priced, highly volatile stock.
New Era Energy & Digital (NUAI) slid during regular trading on Tuesday, falling from its prior close of $2.20 to about $2.01, a decline of -8.64%. No verified news or fundamental catalyst found; the drop is consistent with continued speculative selling in this micro-cap, which has tumbled from roughly $7.65 in late September and typically moves about 6.8% per day.
The central target of $9.30 is the arithmetic mean of five verified analyst price targets reviewed for New Era Energy & Digital, Inc. (NUAI) , rounded from roughly $9.32. With shares recently trading near $2.20 , reaching $9.30 would require an advance of roughly 320% , a very large move by any standard.
BKKT rose +2.58% to $4.77 from Monday's $4.65 close during regular market hours. The gain is a follow-through to Q3 2026 results released after Monday's close: net income swung to a $14.3M profit, helped by a $26.8M non-cash Transchem warrant gain, while revenue fell 62.9% to $149.2M and EPS/revenue missed consensus, alongside reiterated ~$3B 2026 and new $6B H1-2027 volume targets.
Horizon Quantum (HQ) shares rose +2.24% during regular market hours, advancing from the prior close of $13.81 to $14.12. The move followed third-quarter results released before the open, showing GAAP EPS of $0.55 that beat estimates but was driven by a $43.1 million non-cash warrant remeasurement gain, while adjusted EBITDA loss widened to $6.3 million; the company also announced Triple Alpha's pulse-level integration with OQC's processor and a non-binding letter of intent to acquire Entropica Labs.
PGY slipped during regular market hours, falling from a previous close of $18.19 to $17.55, a decline of -3.52%. No verified news or fundamental catalyst found; the move is likely routine profit-taking after the prior session's +3.94% gain, consistent with the stock's typical daily swing of about 3.3%.
RPD fell to $14.47 from its prior close of $14.97, a -3.34% decline, during regular market hours in the early session. The drop tracks broad profit-taking across cybersecurity and software names as Treasury yields surged (10-year near 5.15%), pressuring richly valued tech; no RPD-specific news was released today.
SUPX fell to $5.34 from a prior close of $5.70, down -6.32%, during regular trading hours on November 10. No verified news or fundamental catalyst found. The decline is consistent with profit-taking after the prior session's +16.33% rebound, in a stock that routinely swings by large amounts (roughly 5.3% average daily move).
QLYS dropped -9.87%, from Monday's close of $202.46 to $182.47, during Tuesday's regular trading session. The decline followed third-quarter earnings reported after Monday's close: adjusted EPS of $2.12 beat the $1.96 consensus and revenue of $188 million topped estimates, but adjusted operating margin slipped to 46% from 47% and analysts flagged a fourth-quarter billings-growth slowdown.
QLYS dropped -10.86% during regular market hours, sliding from a $202.46 prior close to about $180.48. The drop follows Q3 results that beat estimates but revealed margin compression, with Q4 billings guidance implying growth slowing to roughly 8% from Q3's 14%.
RPAY fell from a $4.49 prior close to $3.62, down -19.38%, during regular market hours. The drop follows Q3 2026 results reported after Monday's close: a GAAP loss, a cut to normalized organic revenue growth guidance (5%–6% from 7%–9%), and lower free-cash-flow conversion guidance (20%–25% from 30%), with consumer payments organic growth at just +0.3%.
The central EXOD stock price target of $12 is the arithmetic mean of four verified analyst price targets reviewed for this article ($8.50, $12, $12, and $15). With the latest verified share price near $4.48, reaching $12 would require a gain of roughly 168%, a very large move from current levels.
The central target of $5.75 is the arithmetic mean of three recent analyst price targets for Sangoma Technologies ($5.00, $5.64, and $6.55). The latest verified market price is about $4.59, meaning the stock would need roughly 25% upside to reach the target.
Sangoma reported first quarter fiscal 2027 revenue of $50.1 million , slightly ahead of the roughly $49.9 million consensus estimate. The company posted a net loss of $2.9 million , or a $0.09 loss per share on a fully diluted basis, compared with a $2.6 million loss in the same quarter last year.
The central target of $12.50 is the arithmetic mean of two current, attributable analyst price targets: Benchmark at $12 and Clear Street at $13. With a latest verified price near $4.66 , reaching $12.50 would require a gain of roughly 168% — a very large move by any standard.
Bakkt reported third-quarter 2026 revenue of $149.2 million, down 62.9% from $402.2 million a year earlier, reflecting lower crypto trading activity and the gross presentation of crypto services revenue. Net income attributable to Bakkt was $14.3 million, or $0.31 per diluted share, a swing from a $14.9 million net loss in the prior-year quarter, helped by a $26.8 million non-cash gain on Transchem warrants.
The $16 central target is not an analyst consensus; it reflects the $16.00-per-share all-cash acquisition offer Western Union agreed to make, a publicly discussed price objective rather than a fundamental price forecast. Independent analyst coverage is thin and largely anchored to the deal; the widely quoted "$16 consensus" simply mirrors the offer price, while Monness reiterated a Hold with a $13 target in July 2026.
International Money Express (IMXI), which operates under the Intermex brand, is expected to report third-quarter 2026 results after the market close on Monday, November 9, 2026. Wall Street consensus calls for adjusted earnings per share (EPS) of roughly $0.20 on revenue of approximately $128 million to $130 million, implying another year-over-year decline.
The $9 target reflects the high end of current Wall Street coverage — Northland Securities' $9 Buy-rated target — not an average analyst price target; it sits roughly 25% above the latest close near $7.17. Because a post-earnings rally of roughly 49% pushed shares above most published targets, only one current analyst target remains above the price, so $9 is best understood as a publicly discussed objective rather than a consensus.